Just 1 diet soda a day could triple your risk of life-threatening diseases like stroke and dementia, new study warns
A decade-long study following more than 2,800 adults aged 45 and older found that individuals who drank at least one artificially sweetened beverage daily had almost triple the risk of ischemic stroke and Alzheimer's dementia compared to those who seldom consumed these drinks. (Also read: Doctor says these everyday foods can be silently damaging your liver: From cookies, soda to cereals )
What the study reveals
Participants reported their beverage habits, including diet sodas and other cold drinks, at multiple points during the decade-long study. Those who drank one or more artificially sweetened beverages daily had hazard ratios close to 3.0 for ischemic Stroke and Alzheimer's dementia, indicating a significantly higher risk. The research accounted for age, gender, diet quality, and physical activity, adding credibility to the findings. Although the specific types of sweeteners were not detailed, the results contribute to growing concerns about the safety of common artificial additives.
Diet sodas, despite being low in sugar, may disrupt metabolism and gut health due to artificial sweeteners.(REUTERS)
How diet sodas affect the body
Despite containing little or no sugar, diet sodas rely on artificial sweeteners that may disrupt metabolic processes. They can affect gut bacteria, alter glucose regulation, and influence brain chemistry, potentially increasing susceptibility to neurological conditions. Additionally, caffeine and phosphoric acid in sodas may raise blood pressure and deplete essential minerals, both of which can negatively impact cardiovascular and brain health.
Beyond stroke and dementia, regular consumption of diet or sugary sodas has been linked to:
Obesity: 1.6 times higher risk per additional soda
1.6 times higher risk per additional soda Heart disease: 20% higher risk from just one can daily
20% higher risk from just one can daily Type 2 diabetes: 26% higher risk for 1–2 cans per day
26% higher risk for 1–2 cans per day Tooth decay and bone loss: From sugar and acid erosion
From sugar and acid erosion Kidney damage: Sodium and phosphoric acid can harm the kidneys and bones over time
What happens in your body after a soft drink
Immediately: Sugar floods your bloodstream.
Sugar floods your bloodstream. 20 minutes: Blood sugar spikes, triggering insulin release.
Blood sugar spikes, triggering insulin release. 40 minutes: Caffeine is absorbed, increasing blood pressure and releasing more sugar from the liver. Dopamine stimulates the brain's pleasure centres.
Caffeine is absorbed, increasing blood pressure and releasing more sugar from the liver. Dopamine stimulates the brain's pleasure centres. 60 minutes: Phosphoric acid binds calcium and other minerals in the gut, while caffeine's diuretic effect flushes them out through urine.
Lead researchers emphasise that while the study shows a strong link, it doesn't prove that diet sodas directly cause stroke or dementia. Moderation is crucial, and water or natural drinks are safer choices. As evidence of potential harms grows, cutting back on artificially sweetened beverages may help reduce risks to brain and heart health. Further research is needed to fully understand these associations and guide safe dietary choices.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
9 hours ago
- Time of India
Want to boost memory? Music can help, here's how
A recent UCLA study reveals that music can enhance memory, particularly detail-oriented recall, when paired with moderate emotional arousal. The research suggests that music's influence on the hippocampus could be harnessed to improve memory in individuals with Alzheimer's or PTSD. Tailoring music to evoke the right emotional response may offer a non-invasive therapeutic approach. Music is known to be therapeutic, but can it boost your memory? Well, it can. A new study found that listening to music can sharpen the brain and also has the potential to improve the lives of people with neurodegenerative disorders. A new study by UCLA neuroscientists found music's therapeutic potential for Alzheimer's disease, anxiety, and PTSD. The findings of the study are published in the Journal of Neuroscience . Music's impact on the brain We all know that listening to music while doing certain chores makes the activity more enjoyable. The new study found that listening to music after an experience or activity can make it more memorable if you have the optimal emotional response while listening to it. 'We found that whether music was negative or positive, or whether it was familiar, didn't have as much of an influence on memory as the emotional response people felt while listening to it. There was an optimal level of emotional response that aided in remembering the details of an experience. Too much or too little emotional response had to opposite effect – worse memory for details, but better memory for the gist of an experience,' corresponding author and UCLA integrative biology and physiology professor Stephanie Leal said, in a statement. Scientists have been trying to understand the link between music, emotions, and memory so that they could tackle learning and problems involving memory, such as Alzheimer's disease and PTSD. There is no doubt that music could become a powerful, noninvasive, and even pleasant therapeutic tool. The study To understand the link between music and memory, the researchers studied volunteers who were given images of household objects, such as telephones, laptops, and oranges. After observing about 100 images, the participants listened to classical music for 10 minutes. When the emotional arousal levels dropped back down to baseline, they were given tests to see if they had a memory of the objects shown to them. They were shown pictures that were either identical to the images they had seen, ones that were very similar but slightly different, or ones they hadn't seen at all. Participants had to identify if the images were exactly the same, new, or different in any way. They were also asked about their familiarity with the music and how they felt while listening to it. The findings Looking at the whole scenario, music did not improve participants' memory of the objects; however, some showed significant improvement. especially for recognizing that an object wasn't quite the same during the memory test, but similar. The researcher found that individuals with improved memory had experienced a moderate level of emotional arousal, so not too much or too little, whether listening to classical music that sounded uplifting or gloomy, or familiar or unfamiliar. Those who felt strong emotions in either direction, in fact, tended to have the most blurry recall of the objects and remembered the gist of the images better. The takeaway The researchers noted that memory is often a balance between remembering the gist versus the details. Gist-based memory helps us recall the overall thing while letting minor details fade, which is useful since we can't remember everything. Detail-based memory, on the other hand, helps to retain the specific information when needed. 'We used a task designed to tap into the difference between gist- and detail-based memory. Music helped with detail-based memory but only when the level of emotional arousal was just right for that person,' Leal said. This study found that listening to music immediately after an experience can alter what we remember. For instance. Tuning to moderately arousing music after studying might help you remember the detailed information you need for a test the next day. But if you listen to music that provokes strong emotions immediately after studying, it may have the opposite effect. The balance is perhaps the key here. 'Music has the ability to influence a part of your brain called the hippocampus, which is essential for turning experiences into memories. We think it should be possible to tap into that in a selective way to boost or impair memory depending on the therapeutic goals,' Leal added. Music could help people remember details of experiences, keep their minds sharp as they age, which may be helpful for those in the early stages of Alzheimer's. In anxiety and PTSD, music that strengthens gist-based memory might help smooth out experiences that trigger a trauma response. Barbara Palvin Opens Up About Her Hidden Health Battle & Transformative Surgery Recovery 'In my lab, we're trying to detect changes in the brain and cognition early. Music is noninvasive, low-cost, and easy to personalize, and by learning more about the mechanisms that connect it to memory, we can develop treatments and interventions to prevent the disease from progressing. If the federal government reduces funding for Alzheimer's research, the chances that we'll be able to develop this line of research into inexpensive yet effective treatments are very low, as developing personalized treatments requires lots of research participants to capture individual needs,' Leal said.
Time of India
10 hours ago
- Time of India
What other health conditions are weight-loss drugs being used and tested for?
Bengaluru: Novo Nordisk 's weight-loss treatment Wegovy gained U.S. approval to treat a progressive liver condition on Friday, as the Danish drugmaker looks to boost sales and widen insurance coverage. Eli Lilly's blockbuster diabetes drug Mounjaro and related weight-loss therapy Zepbound, and Novo's rival medicines Ozempic and Wegovy brought in combined sales of over $40 billion last year, which is expected to rise to $60 billion in 2025. Here are some of the other conditions the drugs are being used and tested for: Alcohol addiction A study conducted by the University of Copenhagen's Psychiatric Centre Rigshospitalet is investigating whether semaglutide - the main ingredient in Wegovy and Ozempic - can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity . Alzheimer's disease Novo Nordisk is testing semaglutide in a late-stage trial in patients with early Alzheimer's disease. The study, which will enroll 1,840 patients, could have an initial data readout as early as later this year. Cardiovascular disease Eli Lilly was testing tirzepatide - the main ingredient in Mounjaro and Zepbound - for patients with heart failure and obesity. Lilly had said it would enroll about 700 people in the study, but the company said in May that it has withdrawn its U.S. application for heart failure approval. Novo won the U.S. Food and Drug Administration's approval in 2024 to use Wegovy to reduce the risk of cardiovascular death, heart attack and stroke in overweight or obese adults without diabetes. The European Medicines Agency backed the use of Novo's semaglutide to help ease heart failure symptoms in people with obesity in September 2024. Chronic kidney disease Novo's Ozempic is approved in the United States for reducing the risk of kidney failure and disease progression as well as the risk of death due to heart problems in diabetes patients with chronic kidney disease. Lilly's tirzepatide is being evaluated in a mid-stage study of patients with chronic kidney disease and obesity. Lilly plans to enroll up to 140 participants with the study expected to be completed next year. Liver disease Novo's Wegovy in August became the first GLP-1 therapy approved in the U.S. to treat adults with metabolic dysfunction-associated steatohepatitis, or MASH, based on results from the first part of its late-stage trial. Results from the second part, with about 1,200 patients, is expected in 2029. Lilly's tirzepatide in February helped up to 74% of patients achieve absence of MASH with no worsening of liver scarring at 52 weeks, compared with 13% of patients on placebo, in a mid-stage trial. Neurological disorders Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises. The study has enrolled about 50 patients and is expected to complete in October 2025. Sleep apnea Zepbound was approved by the U.S. Food and Drug Administration for obstructive sleep apnea in December 2024, making it the first drug to directly treat patients with the common disorder that causes breathing disruption while sleeping.
Time of India
11 hours ago
- Time of India
Somalia faces diphtheria surge amid vaccine shortages and aid cuts
Mogadishu: Diphtheria cases and deaths have risen sharply this year in Somalia, where the response has been curtailed by vaccine shortages and U.S. aid cuts, Somali officials said. More than 1,600 cases, including 87 deaths, have been recorded, up from 838 cases and 56 deaths in all of 2024, said Hussein Abdukar Muhidin, the general director of Somalia's National Institute of Health. Diphtheria, a bacterial disease that causes swollen glands, breathing problems and fever and mostly affects children, is preventable with a vaccine that became widely available in the mid-20th century. Childhood immunisation rates in Somalia have improved over the past decade, but hundreds of thousands of children are still not fully vaccinated. After fleeing fighting between government forces and Islamist militants in the central Somalia town of Ceeldheere three months ago, all four of Deka Mohamed Ali's children, none of whom was vaccinated, contracted diphtheria. Her 9-year-old daughter recovered, but her 8-year-old son died and two toddlers are now being treated at a hospital in the capital Mogadishu. "My children got sick and I just stayed at home because I did not know it was diphtheria," she told Reuters from the bedside of her 3-year-old son Musa Abdullahi whose throat was swollen to the size of a lemon from the infection. Health Minister Ali Haji Adam said the government had struggled to procure enough vaccines due to a global shortage and that U.S. aid cuts were making it difficult to distribute the doses it had. Before President Donald Trump cut most foreign assistance earlier this year, the United States was the leading humanitarian donor to Somalia, whose health budget is almost entirely funded by donors. "The U.S. aid cut terribly affected the health funds it used to provide to Somalia. Many health centres closed. Mobile vaccination teams that took vaccines to remote areas lost funding and now do not work," said Adam. Muhidin separately echoed his comments about the closures. Overall U.S. foreign assistance commitments to Somalia stand at $149 million for the fiscal year that ends on September 30, compared with $765 million in the previous fiscal year, according to U.S. government statistics. "The United States continues to provide lifesaving foreign assistance in Somalia," a U.S. State Department spokesperson said when asked about the impact of its aid cuts in the country. "America is the most generous nation in the world, and we urge other nations to dramatically increase their humanitarian efforts." Aid group Save the Children said last month that the closure of hundreds of health clinics in Somalia this year due to foreign cuts has contributed to a doubling in the number of combined cases of diphtheria, measles, whooping cough, cholera and severe respiratory infections since mid-April. Besides the U.S., Britain, France, Germany and other major Western donors are also cutting aid budgets. Somalia's government has also faced criticism from doctors and human rights activists for its limited funding of the health sector. In 2024, it allocated 4.8% of its budget to health, down from 8.5% the previous year, Amnesty International said. The health ministry did not respond to a question about that criticism. It has said it is planning to launch a vaccination drive but has not given details when.
